Boise Cascade Co. BCC 深 沪
等待开盘 06-25 09:30:00 美东时间
77.66
+5.860
+8.16%
华盛通- 最 高77.77
- 今 开72.45
- 成交量 43.16万股
- 最 低 72.05
- 昨 收 71.80
- 总市值 27.33亿
- 52周最高 94.12
- 市盈率 静 21.99
- 换手率 1.23%
- 52周最低 64.48
- 委 比 14.29%
- 总股本 3518.97万
- 历史最高 153.91
- 量 比 0.90
- 振 幅 7.97%
- 历史最低 -16.19
- 每 手 1
- 风险率 7.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Brunswick Corporation Announces Operational Updates at Lowell Facility
Navico Group, a division of Brunswick Corporation, announced operational updates at its Lowell, Michigan facility to reduce costs, improve efficiency, and support long-term growth. The changes include expanding insourcing, collaborating with external partners, and integrating more closely with other Brunswick divisions. Land ‘N’ Sea will utilize 50,000 square feet of Lowell's space for distribution, while maintaining its independence. These actio...
06-22 11:00
J&J avoiding GLP-1 space to focus on cancer drugs
Johnson & Johnson (JNJ) CEO Joaquin Duato says his company has no plans to venture into the fast-growing market for GLP-1 obesity drugs and will instead focus on treatments for conditions such as canc...
06-18 00:20
Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations
Provident Bank has awarded $1 million to ten non-profit organizations in New Jersey to support neighborhood revitalization plans. The funds will address housing, economic development, job training, and community activities. The New Jersey Department of Community Affairs administers the Neighborhood Revitalization Tax Credit Program, which provides tax credits to corporations contributing funds. The program aims to revitalize at-risk neighborhood...
06-17 12:00
Wise announces dates for FY2026 results and Q1 FY2027 trading update
Wise Group plc announces the release of its FY2026 financial results and FY2027 Q1 trading update, with webcasts scheduled for June 25 and July 16, 2026, respectively. Both events will be live-streamed on the company's Owner Relations website, along with earnings press releases, and replays will be available for 30 days. Wise, a global technology company, facilitates cross-border money transfers and management, supporting millions of users and pr...
06-15 15:45
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom DXCM.O glucose sensors it bought from licensed distributors had been slated for destruction, after the device maker warned some unit
06-11 18:05
A.I.S. Resources expands New Brunswick land package to 25,683 hectares with 16,128-hectare acquisition
A.I.S. Resources expands New Brunswick land package to 25,683 hectares with 16,128-hectare acquisition A.I.S. Resources expanded its Southwestern New Brunswick land package to 25,683 hectares from 9,555 hectares. The transaction added 16,128 hectares, extending the company’s exposure to mineralized
06-09 18:31
J&J cleared in talc-related cancer lawsuit in California
A jury in Los Angeles, California, has found that Johnson & Johnson (JNJ) was not negligent when selling its talc-based cosmetic powder in a lawsuit brought by families of three women who allegedly d...
06-06 20:45
Viridien: Combined General Meeting and Board of Directors Meeting of June 3, 2026 - Henning Berg appointed as Chief Executive Officer and Director of Viridien
Viridien's Combined General Meeting on June 3, 2026, in Paris approved key resolutions, including appointing Henning Berg as CEO and Director. Sophie Zurquiyah remains Chair of the Board. Shareholders supported the agenda, with resolutions on financial statements, Say on Pay, and board authorizations. The Board now has 9 members, 78% independent and 44% women. Berg, with over 27 years of energy leadership, succeeds Zurquiyah, who led the company'...
06-03 14:40
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
HUTCHMED and Innovent announce NMPA approval for the combination of ELUNATE® (fruquintinib) and TYVYT® (sintilimab) for second-line treatment of locally advanced or metastatic renal cell carcinoma in China. The approval is supported by the FRUSICA-2 study, which showed a 63% reduction in disease progression or death, with a median PFS of 22.2 months. The combination demonstrated superior efficacy and safety compared to axitinib or everolimus mono...
05-21 10:00
Morgan Stanley Maintains Equal-Weight on Brunswick, Raises Price Target to $86
Morgan Stanley analyst Megan Alexander maintains Brunswick (NYSE:BC) with a Equal-Weight and raises the price target from $82 to $86.
05-19 21:35
